These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2855367)

  • 21. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ; Domino EF
    J Pharmacol Exp Ther; 1984 Nov; 231(2):306-11. PubMed ID: 6092613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M; Ramabadran K; Turndorf H; Shukla VK
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice.
    Kudryavtseva NN; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM
    Peptides; 2004 Aug; 25(8):1355-63. PubMed ID: 15350704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P; Bhargava HN
    Pharmacol Biochem Behav; 1989 Jun; 33(2):375-80. PubMed ID: 2554341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the rat.
    Cooper SJ; Moores WR; Jackson A; Barber DJ
    Neuropharmacology; 1985 Sep; 24(9):877-83. PubMed ID: 2997653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tifluadom on passive avoidance behaviour in DBA/2 mice.
    Pavone F; Castellano C
    Behav Brain Res; 1985 May; 15(3):177-81. PubMed ID: 2988580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kappa agonists PD117302 and U50488 produce a biphasic effect on 24 hour food intake in the rat.
    Hewson G; Hill RG; Hughes J; Leighton GE; Turner WD
    Neuropharmacology; 1987 Nov; 26(11):1581-4. PubMed ID: 2829048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kappa agonists and vasopressin secretion.
    Hamon G; Jouquey S
    Horm Res; 1990; 34(3-4):129-32. PubMed ID: 1966562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycaemia as a factor affecting kappa-opiate agonist-induced inhibition of the gastrointestinal transit in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Pharm Pharmacol; 1989 Jul; 41(7):496-8. PubMed ID: 2570861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the opioid benzodiazepine tifluadom and its optical isomers on spontaneous locomotor activity of mice.
    Ruhland M; Zeugner H
    Life Sci; 1983; 33 Suppl 1():631-4. PubMed ID: 6319918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do kappa opioids mimic sigma agonists as amino acid antagonists?
    Parsons CG; Martin D; Franklin RJ; Wood JL; Headley PM
    Neuropharmacology; 1986 Feb; 25(2):217-20. PubMed ID: 3010163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular basis for opioid-induced immunosuppression.
    Guan L; Townsend R; Eisenstein TK; Adler MW; Rogers TJ
    Adv Exp Med Biol; 1995; 373():57-64. PubMed ID: 7668161
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
    Kunihara M; Ohyama M; Nakano M
    Jpn J Pharmacol; 1993 Jul; 62(3):223-30. PubMed ID: 8411771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple opioid receptors.
    Burks T
    NIDA Res Monogr; 1988; 81():353-62. PubMed ID: 2841604
    [No Abstract]   [Full Text] [Related]  

  • 39. Opioid kappa receptors correlate with the development of conditioned suppression of motility in mice.
    Nabeshima T; Kamei H; Kameyama T
    Eur J Pharmacol; 1988 Jul; 152(1-2):129-33. PubMed ID: 2850197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain-dependent effects of cocaine on memory storage improvement induced by post-training physostigmine.
    Castellano C; Zocchi A; Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 1996 Feb; 123(4):340-5. PubMed ID: 8867873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.